vanilmandelic acid has been researched along with Dyslipidemia in 1 studies
Vanilmandelic Acid: A 3-O-methyl ether of 3,4-dihydroxymandelic acid. It is an end-stage metabolite of CATECHOLAMINES; EPINEPHRINE; and NOREPINEPHRINE.
vanillylmandelic acid : An aromatic ether that is the 3-O-methyl ether of 3,4-dihydroxymandelic acid.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Navarro, I | 1 |
| Molina, M | 1 |
| Civera, M | 1 |
| Ascaso, JF | 1 |
| Real, JT | 1 |
| Carmena, R | 1 |
1 review available for vanilmandelic acid and Dyslipidemia
| Article | Year |
|---|---|
[Catecholamine-induced cardiomyopathy triggered by pheochromocytoma].
Topics: 3-Iodobenzylguanidine; Acute Coronary Syndrome; Adrenal Gland Neoplasms; Adrenalectomy; Catecholamin | 2011 |